________________________________________________________________________________________________________________________________

(C) Wolf G Kroner 2010 - Dr Robert Berendes

Robert Berendes leaves Syngenta

08-01-2014. Robert Berendes, Syngenta’s Head of Business Development and ad interim Head of Research is leaving the company after eleven years. In a ten-lines “Management announcement” he has been discharged with thanks “for his outstanding contributions”. Dr. Berendes is officially quit his post end of March and join as partner a-connect (group) ag at Zürich next autumn.

a-connect is a strategy advisory and human resource outplacement firm, which was founded in 2002 by former McKinsey consultants Swiss lawyer Nils Hagander and Norwegian Hanne de Mora together with Didier Sangiorgio also a lawyer and business angel investor. Recently the consultancy has been expanding in the U.S. and Asia with new offices. It has taken in additional collaborators and placed a special focus on life sciences.

Robert Berendes brings truly global expertise at the interface of chemical and biotech to his new company. In addition he is well-connected to major political and economic networks in his field. He learned to know a-connect during many years as his preferred service provider for Syngenta’s business development. A statement in a customer interview (Hagander 2007) many years ago may well explain why Mr. Berendes finally said “ade” (goodbye) to Syngenta to join his former service supplier. Asked what typical challenges large companies like Syngenta encounter when developing business, he answered: “Small scale growth projects do not always get sufficient attention, as they sometimes operate in the shadow of the large core businesses; also, because of their sub-critical size it is sometimes difficult to provide them with adequate resources required in the early stages of business building.” For someone dedicated to building new businesses opportunities and developing emerging markets it may have been too attractive to leave the shadow acting on front stage. Arvid Lønsson

Reference
Nils Hagander (2007) Interview with Robert Berendes, Head of Business Development, Syngenta - a-connect and business development - a powerful combination. June: http://www.imakenews.com/aconnect/e_article000817713.cfm?x=0,w.

 

Copyright Notice
Please note: You may freely distribute the link to this article. Any copying, distributing, or publishing of the entire article or parts of it (picture included) requires prior written consent by B2Bioworld or by third parties retaining copyrights. All rights reserved.

This editorial article is brought to you free oof charge. You may see how we work, investigate issues,
and write up results in articles free of advertising and normally at cost. Enjoy reading

Back to section

Related Editorial Articles

Sandro Aruffo's Syngenta Legacy
The late Head of R&D and Robert Berendes, Head of Business Development in a candid conversation about plant biotechnology, cross-fertilization with organic farming, agrichemicals, and prospects in Africa and Asia

Riding ahead of demand in the trade fair industry
Jochen Köckler of Deutsche Messe AG about strategic assumptions and business in different parts of the world

Corporate Compliance: Training the paper tiger to purr, show its teeth, or jump on
Michael Schulz, CFO of Bayer CropScience and Compliance Officer

Pharma Boost for Red Cross/Red Crescent
- Community Disease Prevention Programme

Bio-based economy? What's in it for business?
An industry perspective and key trends in an emerging lead market

Roche Ethiopia: Build-up of an emerging market

Metrics for Disease, Health, and Wellness
Personalized medicine? A systems look at human genetic diagnostics and the road ahead for next-generation sequencing by Leroy Hood, Institute for Systems Biology at Seattle

Industrial Bioscience: Solutions marketing never dreamt of…
David Nicholson, past CSO of Bayer CropScience on hidden potentials, revaluation of IP assets, and substantial changes in R&D